Nontuberculous Mycobacteria in Cystic Fibrosis

[1]  Z. Chisty,et al.  Investigation of Mycobacterium abscessus outbreak among cystic fibrosis patients, Hawaii 2012. , 2016, The Journal of hospital infection.

[2]  C. Haworth,et al.  Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF). , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[3]  L. Kremer,et al.  MgtC as a Host-Induced Factor and Vaccine Candidate against Mycobacterium abscessus Infection , 2016, Infection and Immunity.

[4]  C. Biot,et al.  A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus , 2016, Molecular microbiology.

[5]  Peter J. Diggle,et al.  Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis☆ , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[6]  P. Flume.  US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[7]  R. Gibson,et al.  US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary , 2015, Thorax.

[8]  Inês João,et al.  General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection , 2015, Journal of pathogens.

[9]  N. Høiby,et al.  Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection , 2015, European Respiratory Journal.

[10]  Po-Ren Hsueh,et al.  Mycobacterium abscessus Complex Infections in Humans , 2015, Emerging infectious diseases.

[11]  P. Burgel,et al.  Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[12]  C. Goss,et al.  Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus , 2015, Antimicrobial Agents and Chemotherapy.

[13]  C. Colombo,et al.  Cystic fibrosis mortality trend in Italy from 1970 to 2011. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[14]  D. Taylor-Robinson,et al.  Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[15]  L. Kremer,et al.  β-Lactamase inhibition by avibactam in Mycobacterium abscessus. , 2014, The Journal of antimicrobial chemotherapy.

[16]  L. Kremer,et al.  In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  V. Waters,et al.  Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi. , 2014, Annals of the American Thoracic Society.

[18]  L. Bermudez,et al.  Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection , 2014, PloS one.

[19]  J. Adjemian,et al.  Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk. , 2014, American journal of respiratory and critical care medicine.

[20]  L. Saiman,et al.  Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update , 2014, Infection Control & Hospital Epidemiology.

[21]  N. Høiby,et al.  Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis , 2014, Respiratory Research.

[22]  R. Wallace,,et al.  Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections , 2014, The Journal of antimicrobial chemotherapy.

[23]  Nalin Rastogi,et al.  Multilocus sequence typing scheme for the Mycobacterium abscessus complex. , 2014, Research in microbiology.

[24]  J. Nick,et al.  Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. , 2014, Annals of the American Thoracic Society.

[25]  M. Surette.  The cystic fibrosis lung microbiome. , 2014, Annals of the American Thoracic Society.

[26]  J. Leung,et al.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis , 2013, Current opinion in pulmonary medicine.

[27]  Emiy Yokoyama,et al.  Correlación genotipo-fenotipo en una muestra de pacientes mexicanos con fibrosis quística , 2013 .

[28]  J. Adjemian,et al.  Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. , 2013, American journal of respiratory and critical care medicine.

[29]  P. Gilligan,et al.  Lung transplant outcomes in cystic fibrosis patients with pre‐operative Mycobacterium abscessus respiratory infections , 2013, Clinical transplantation.

[30]  M. Newport,et al.  Prevalence of Nontuberculous Mycobacteria in Cystic Fibrosis Clinics, United Kingdom, 2009 , 2013, Emerging infectious diseases.

[31]  J. Parkhill,et al.  Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study , 2013, The Lancet.

[32]  C. Goss,et al.  Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. , 2012, American journal of respiratory and critical care medicine.

[33]  D. Rubinsztein,et al.  Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. , 2011, The Journal of clinical investigation.

[34]  Young Kil Park,et al.  Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. , 2011, American journal of respiratory and critical care medicine.

[35]  P. Burgel,et al.  Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. , 2010, Medical mycology.

[36]  Youngchul Kim,et al.  The Impact of the 2007 ATS/IDSA Diagnostic Criteria for Nontuberculous Mycobacterial Disease on the Diagnosis of Nontuberculous Mycobacterial Lung Disease , 2010, Respiration.

[37]  W. R. Butler,et al.  Utility of high-performance liquid chromatography analysis of mycolic acids and partial 16S rRNA gene sequencing for routine identification of Mycobacterium spp. in a national reference laboratory. , 2010, Diagnostic microbiology and infectious disease.

[38]  F. Accurso,et al.  Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures , 2010, Pediatric Pulmonology.

[39]  P. Gilligan,et al.  Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. , 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[40]  Young Kil Park,et al.  Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. , 2009, American journal of respiratory and critical care medicine.

[41]  J. Gaillard,et al.  Multicenter Study of Prevalence of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis in France , 2009, Journal of Clinical Microbiology.

[42]  S. Holland,et al.  Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs. , 2009, Respiratory medicine.

[43]  H. Scherstén,et al.  Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[44]  S. Conlan,et al.  Cohort Study of Molecular Identification and Typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii , 2009, Journal of Clinical Microbiology.

[45]  John D. Mitchell,et al.  Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  K. Nash,et al.  A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae , 2009, Antimicrobial Agents and Chemotherapy.

[47]  E. Picard,et al.  Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel , 2008, Emerging infectious diseases.

[48]  N. Ampel.  Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases , 2007 .

[49]  C. Goss,et al.  Exacerbations in cystic fibrosis · 1: Epidemiology and pathogenesis , 2007, Thorax.

[50]  A. Humar,et al.  Mycobacterium abscessus infections in lung transplant recipients: the international experience. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[51]  S. Garay,et al.  Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. , 2006, American journal of respiratory and critical care medicine.

[52]  R. Aris,et al.  Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation , 2006, Thorax.

[53]  J. Zieleński,et al.  Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes. , 2005, The Journal of pediatrics.

[54]  P. Molina,et al.  Nontuberculous mycobacterial infection in young children with cystic fibrosis , 2005, Pediatric pulmonology.

[55]  P. Suffys,et al.  A Comparison of Mycolic Acid Analysis for Nontuberculous Mycobacteria Identification by Thin‐Layer Chromatography and Molecular Methods , 2005, Microbiology and immunology.

[56]  P. Berche,et al.  Age-Related Prevalence and Distribution of Nontuberculous Mycobacterial Species among Patients with Cystic Fibrosis , 2005, Journal of Clinical Microbiology.

[57]  H. Mussaffi,et al.  Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy , 2005, European Respiratory Journal.

[58]  M. Corey,et al.  Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. , 2004, Chest.

[59]  S. Field,et al.  Mycobacterium avium complex pulmonary disease in patients without HIV infection. , 2004, Chest.

[60]  D. Curran‐Everett,et al.  Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[61]  S. Field,et al.  Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine. , 2003, Chest.

[62]  Y. Kobashi,et al.  The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease. , 2003, Internal medicine.

[63]  B. Petrini,et al.  Early chemotherapy for non‐tuberculous mycobacterial infections in patients with cystic fibrosis , 2003, Acta paediatrica.

[64]  P. Molina,et al.  Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. , 2003, American journal of respiratory and critical care medicine.

[65]  Yansheng Zhang,et al.  Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[66]  E. Böttger,et al.  Improved Decontamination Method for Recovering Mycobacteria from Patients with Cystic Fibrosis , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[67]  R. Wallace,,et al.  Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[68]  P. Cegielski,et al.  Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[69]  A. Glanville,et al.  The spectrum of mycobacterial infection after lung transplantation. , 1999, American journal of respiratory and critical care medicine.

[70]  A. Niimi,et al.  Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[71]  B. Strandvik,et al.  Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease. , 1999, The European respiratory journal.

[72]  W. Guggino.  Cystic Fibrosis and the Salt Controversy , 1999, Cell.

[73]  J. Treluyer,et al.  Drug Disposition in Cystic Fibrosis , 1998, Clinical pharmacokinetics.

[74]  P. Dawkins,et al.  Non-tuberculous mycobacteria in cystic fibrosis , 1998, Thorax.

[75]  A. Clément,et al.  Mycobacterial lung disease in cystic fibrosis: a prospective study. , 1997, The Pediatric infectious disease journal.

[76]  R. Wallace,,et al.  Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. , 1996, American journal of respiratory and critical care medicine.

[77]  P. Gilligan,et al.  Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis , 1993, Journal of clinical microbiology.

[78]  S. Hananya,et al.  Increasing nontuberculous mycobacteria infection in cystic fibrosis. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[79]  Shaf Keshavjee,et al.  A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[80]  L. Kremer,et al.  b-Lactamase inhibition by avibactam in Mycobacterium abscessus , 2015 .

[81]  L. Orozco,et al.  [Genotype-phenotype correlation in a sample of Mexican patients with cystic fibrosis]. , 2013, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[82]  J. Gaillard,et al.  Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[83]  M. Iversen,et al.  Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population. , 2013, Transplantation proceedings.

[84]  Mikio Oka,et al.  A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. , 2007, Respiratory medicine.